nodes	percent_of_prediction	percent_of_DWPC	metapath
Mestranol—Ethinyl Estradiol—CYP2B6—malignant glioma	0.0101	0.271	CrCbGaD
Mestranol—Methyltestosterone—CYP2B6—malignant glioma	0.0092	0.247	CrCbGaD
Mestranol—Dextromethorphan—CYP2B6—malignant glioma	0.00914	0.246	CrCbGaD
Mestranol—Estrone—CYP2B6—malignant glioma	0.00877	0.236	CrCbGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.0053	0.0055	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00526	0.00546	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CDKN2A—malignant glioma	0.00516	0.00536	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—TERT—malignant glioma	0.00513	0.00533	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00507	0.00526	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00502	0.00521	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00501	0.0052	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00495	0.00514	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00485	0.00504	CbGpPWpGaD
Mestranol—ESR1—Estrogen signaling pathway—PIK3CA—malignant glioma	0.00481	0.005	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—HIF1A—malignant glioma	0.0048	0.00498	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.00464	0.00482	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0046	0.00478	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.00449	0.00466	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—malignant glioma	0.00432	0.00449	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—MMP2—malignant glioma	0.00429	0.00446	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—EGF—malignant glioma	0.00428	0.00444	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—BAD—malignant glioma	0.00413	0.00429	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.0041	0.00426	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—PTPN11—malignant glioma	0.00393	0.00408	CbGpPWpGaD
Mestranol—ESR1—Estrogen signaling pathway—AKT1—malignant glioma	0.00393	0.00408	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—BCL2—malignant glioma	0.00387	0.00402	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—IFNG—malignant glioma	0.00384	0.00399	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.0038	0.00394	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00375	0.0039	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00359	0.00373	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CXCL8—malignant glioma	0.00357	0.00371	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.00354	0.00367	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—MYC—malignant glioma	0.0035	0.00364	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—MYC—malignant glioma	0.00343	0.00357	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.00343	0.00356	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—IFNG—malignant glioma	0.00343	0.00356	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—IFNG—malignant glioma	0.00335	0.00348	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	0.00333	0.00345	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—malignant glioma	0.0033	0.00342	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00327	0.0034	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.00325	0.00338	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.00318	0.00331	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—RAF1—malignant glioma	0.00314	0.00326	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CXCL8—malignant glioma	0.00311	0.00323	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—ERBB2—malignant glioma	0.00311	0.00323	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00307	0.00319	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—NCOR1—malignant glioma	0.00306	0.00318	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—IL2—malignant glioma	0.00304	0.00316	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.00303	0.00315	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—malignant glioma	0.00303	0.00315	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00303	0.00314	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.00301	0.00312	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—IL2—malignant glioma	0.00297	0.00309	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PDGFRA—malignant glioma	0.00293	0.00304	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00292	0.00303	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—IL1B—malignant glioma	0.00283	0.00293	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—TP53—malignant glioma	0.00282	0.00293	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MMP9—malignant glioma	0.00282	0.00292	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—PTEN—malignant glioma	0.0028	0.00291	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00271	0.00282	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00269	0.00279	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00266	0.00276	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PDGFB—malignant glioma	0.00263	0.00273	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.00262	0.00273	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—FGFR1—malignant glioma	0.00262	0.00272	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—malignant glioma	0.0025	0.0026	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—malignant glioma	0.00247	0.00257	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00244	0.00254	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—MYC—malignant glioma	0.00238	0.00247	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—STAT3—malignant glioma	0.00237	0.00246	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00236	0.00245	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—BAD—malignant glioma	0.00235	0.00244	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—EGFR—malignant glioma	0.00233	0.00242	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MYC—malignant glioma	0.00233	0.00242	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—CD80—malignant glioma	0.00228	0.00237	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—EGF—malignant glioma	0.00225	0.00233	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PTPN11—malignant glioma	0.00223	0.00232	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00218	0.00227	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LATS2—malignant glioma	0.00217	0.00225	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.00215	0.00223	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00215	0.00223	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—AKT2—malignant glioma	0.00208	0.00216	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00208	0.00216	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00207	0.00215	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00202	0.00209	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PIK3CD—malignant glioma	0.002	0.00208	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00196	0.00203	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—FGF2—malignant glioma	0.00191	0.00199	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—TP53—malignant glioma	0.00191	0.00198	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00189	0.00197	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00187	0.00194	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00183	0.0019	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.0018	0.00187	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—MDM2—malignant glioma	0.00179	0.00186	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—RAF1—malignant glioma	0.00178	0.00185	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—ERBB2—malignant glioma	0.00176	0.00183	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PIK3CB—malignant glioma	0.00174	0.00181	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00173	0.0018	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—AKT1—malignant glioma	0.00165	0.00171	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LATS1—malignant glioma	0.00164	0.00171	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00161	0.00167	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00159	0.00166	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00155	0.00161	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—AKT1—malignant glioma	0.00153	0.00159	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00151	0.00157	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.00151	0.00157	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—RTEL1—malignant glioma	0.00151	0.00157	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PTEN—malignant glioma	0.00151	0.00156	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.00149	0.00155	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00149	0.00155	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00149	0.00154	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.00147	0.00153	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00147	0.00153	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00144	0.00149	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.00144	0.00149	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.00137	0.00142	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00134	0.00139	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00133	0.00139	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	0.00127	0.00132	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00126	0.00131	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00125	0.0013	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.00123	0.00128	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—EGFR—malignant glioma	0.00122	0.00127	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—DNMT3B—malignant glioma	0.00118	0.00123	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.00116	0.00121	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—KRAS—malignant glioma	0.00116	0.0012	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—HIST1H3B—malignant glioma	0.00115	0.00119	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00113	0.00118	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MDK—malignant glioma	0.00111	0.00115	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00108	0.00112	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	0.00106	0.0011	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—DTX1—malignant glioma	0.00106	0.0011	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00104	0.00108	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00104	0.00108	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00103	0.00107	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00102	0.00106	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000971	0.00101	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000963	0.001	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000962	0.000999	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	0.000908	0.000943	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—H3F3A—malignant glioma	0.000888	0.000923	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000884	0.000919	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000872	0.000906	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—AKT1—malignant glioma	0.000867	0.000901	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—COX8A—malignant glioma	0.000866	0.0009	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000856	0.000889	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SUFU—malignant glioma	0.000842	0.000874	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH3—malignant glioma	0.000834	0.000866	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HEY2—malignant glioma	0.000831	0.000863	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GFAP—malignant glioma	0.000812	0.000843	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SPHK1—malignant glioma	0.000786	0.000816	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000774	0.000804	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCR4—malignant glioma	0.00077	0.000799	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HEY1—malignant glioma	0.00077	0.000799	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH2—malignant glioma	0.000748	0.000777	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000748	0.000777	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ASMT—malignant glioma	0.000736	0.000765	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000723	0.00075	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00072	0.000748	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—BCAN—malignant glioma	0.000692	0.000719	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—JAG2—malignant glioma	0.000683	0.000709	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—CDKN2B—malignant glioma	0.000643	0.000668	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NCOR1—malignant glioma	0.00061	0.000633	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—H3F3A—malignant glioma	0.000578	0.0006	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCR3—malignant glioma	0.000572	0.000594	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—IDH2—malignant glioma	0.000558	0.00058	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NTRK2—malignant glioma	0.000557	0.000578	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—YWHAE—malignant glioma	0.000557	0.000578	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FLT1—malignant glioma	0.000554	0.000575	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—DUSP6—malignant glioma	0.000552	0.000573	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—JAG1—malignant glioma	0.000545	0.000566	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH3—malignant glioma	0.000542	0.000563	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FBXW7—malignant glioma	0.000534	0.000554	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000526	0.000547	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000525	0.000545	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—BDKRB2—malignant glioma	0.000523	0.000543	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—MYC—malignant glioma	0.000518	0.000538	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH2—malignant glioma	0.000486	0.000505	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—IDH1—malignant glioma	0.00048	0.000499	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KNG1—malignant glioma	0.000476	0.000494	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000464	0.000482	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH1—malignant glioma	0.000463	0.000481	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000455	0.000473	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NTRK1—malignant glioma	0.000454	0.000471	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PPARG—malignant glioma	0.000437	0.000454	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000429	0.000446	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP3—malignant glioma	0.000422	0.000438	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CDKN2B—malignant glioma	0.000418	0.000434	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTK2—malignant glioma	0.000406	0.000422	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HES1—malignant glioma	0.000399	0.000414	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NCOR1—malignant glioma	0.000397	0.000412	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000391	0.000406	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDGFRA—malignant glioma	0.00038	0.000394	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000377	0.000392	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SPP1—malignant glioma	0.000369	0.000383	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000368	0.000382	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TERT—malignant glioma	0.000349	0.000363	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000345	0.000358	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000344	0.000357	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDGFB—malignant glioma	0.000341	0.000354	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGFR1—malignant glioma	0.000339	0.000352	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIF1A—malignant glioma	0.000334	0.000347	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CAV1—malignant glioma	0.000323	0.000336	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—BCHE—malignant glioma	0.000321	0.000333	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KDR—malignant glioma	0.00032	0.000332	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000317	0.000329	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—F2—malignant glioma	0.000308	0.00032	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FN1—malignant glioma	0.000308	0.00032	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—BAD—malignant glioma	0.000304	0.000316	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH1—malignant glioma	0.000301	0.000313	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000299	0.000311	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000297	0.000308	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CD80—malignant glioma	0.000295	0.000306	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APC—malignant glioma	0.000294	0.000306	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CG—malignant glioma	0.000294	0.000306	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGF—malignant glioma	0.000291	0.000302	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTPN11—malignant glioma	0.000289	0.0003	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—BRAF—malignant glioma	0.000277	0.000287	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKT2—malignant glioma	0.000269	0.00028	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CD—malignant glioma	0.000259	0.000269	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000259	0.000269	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTP1—malignant glioma	0.000255	0.000265	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—MYC—malignant glioma	0.000249	0.000259	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CAT—malignant glioma	0.000248	0.000258	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGF2—malignant glioma	0.000248	0.000257	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NCOR1—malignant glioma	0.000234	0.000243	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MDM2—malignant glioma	0.000232	0.000241	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—RAF1—malignant glioma	0.000231	0.00024	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ERBB2—malignant glioma	0.000229	0.000237	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CB—malignant glioma	0.000226	0.000234	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL8—malignant glioma	0.000217	0.000225	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CASP3—malignant glioma	0.000208	0.000216	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IL2—malignant glioma	0.000207	0.000215	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP9—malignant glioma	0.000196	0.000204	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTEN—malignant glioma	0.000195	0.000202	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CAV1—malignant glioma	0.000191	0.000198	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000183	0.00019	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VEGFA—malignant glioma	0.000176	0.000183	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—STAT3—malignant glioma	0.000174	0.000181	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CG—malignant glioma	0.000174	0.000181	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—AKT1—malignant glioma	0.000173	0.000179	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PPARG—malignant glioma	0.000168	0.000174	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MYC—malignant glioma	0.000162	0.000168	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGFR—malignant glioma	0.000158	0.000165	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CD—malignant glioma	0.000153	0.000159	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KRAS—malignant glioma	0.00015	0.000155	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CA—malignant glioma	0.000138	0.000143	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CB—malignant glioma	0.000133	0.000139	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TP53—malignant glioma	0.000133	0.000138	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS2—malignant glioma	0.000132	0.000137	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTEN—malignant glioma	0.000115	0.00012	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKT1—malignant glioma	0.000112	0.000117	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CA—malignant glioma	8.13e-05	8.44e-05	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AKT1—malignant glioma	6.64e-05	6.9e-05	CbGpPWpGaD
